Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
injectable
Biotech
Moderna's $500M pact with Nanexa to improve injectables delivery
Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to four injectable therapies.
James Waldron
Dec 11, 2025 7:35am
J&J adds 2nd molecule to Midatech long-acting injectable pact
Mar 9, 2022 9:05am
'Robotic pill' developer Rani Therapeutics nets $69M in funding
Dec 10, 2020 3:20pm
B. Braun Medical names new chairman, CEO for 2020
Dec 17, 2019 2:55pm
AptarGroup buys up Nanopharm, Gateway Analytical
Jun 12, 2019 7:57am
Crinetics raises $63.5M for oral acromegaly therapy
Mar 14, 2018 9:10am